Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Steiner

Showing results (211-220 of 220) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 220 results.
Diagnostic Microbiology and Infectious Disease|June 27, 2018
A conserved Leishmania hypothetical protein evaluated for the serodiagnosis of canine and human visceral and tegumentary leishmaniasis, as well as a serological marker for the posttreatment patient follow-upPatrícia A F Ribeiro, Daniel S Dias, Daniela P Lage, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 15, 2015
Histoplasmosis complicating tumor necrosis factor-α blocker therapy: a retrospective analysis of 98 casesPaschalis Vergidis, Robin K Avery, L Joseph Wheat, et al.
NPJ Vaccines|August 22, 2020
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against <i>Leishmania infantum</i> infectionDaniela P Lage, Patrícia A F Ribeiro, Daniel S Dias, et al.
Microbial Pathogenesis|June 3, 2020
Biotechnological applications from a Leishmania amastigote-specific hypothetical protein in the canine and human visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Grasiele S V Tavares, et al.
Experimental Parasitology|July 6, 2020
A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human diseaseAmanda S Machado, Fernanda F Ramos, Thaís T O Santos, et al.
Acta Tropica|December 25, 2019
A Leishmania infantum hypothetical protein evaluated as a recombinant protein and specific B-cell epitope for the serodiagnosis and prognosis of visceral leishmaniasisAmanda S Machado, Fernanda F Ramos, João A Oliveira-da-Silva, et al.
Immunology Letters|January 26, 2020
Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Fernanda F Ramos, et al.
Parasitology Research|June 15, 2020
Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cellsPatrícia A F Ribeiro, Daniel S Dias, Daniela P Lage, et al.
Cellular Immunology|November 13, 2017
Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasisDaniel S Dias, Patrícia A F Ribeiro, Vívian T Martins, et al.
Cytokine|February 17, 2020
Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasisPatrícia A F Ribeiro, Danniele L Vale, Daniel S Dias, et al.
Pageof 22

Showing results (211-220 of 220) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 220 results.
Diagnostic Microbiology and Infectious Disease|June 27, 2018
A conserved Leishmania hypothetical protein evaluated for the serodiagnosis of canine and human visceral and tegumentary leishmaniasis, as well as a serological marker for the posttreatment patient follow-upPatrícia A F Ribeiro, Daniel S Dias, Daniela P Lage, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 15, 2015
Histoplasmosis complicating tumor necrosis factor-α blocker therapy: a retrospective analysis of 98 casesPaschalis Vergidis, Robin K Avery, L Joseph Wheat, et al.
NPJ Vaccines|August 22, 2020
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against <i>Leishmania infantum</i> infectionDaniela P Lage, Patrícia A F Ribeiro, Daniel S Dias, et al.
Microbial Pathogenesis|June 3, 2020
Biotechnological applications from a Leishmania amastigote-specific hypothetical protein in the canine and human visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Grasiele S V Tavares, et al.
Experimental Parasitology|July 6, 2020
A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human diseaseAmanda S Machado, Fernanda F Ramos, Thaís T O Santos, et al.
Acta Tropica|December 25, 2019
A Leishmania infantum hypothetical protein evaluated as a recombinant protein and specific B-cell epitope for the serodiagnosis and prognosis of visceral leishmaniasisAmanda S Machado, Fernanda F Ramos, João A Oliveira-da-Silva, et al.
Immunology Letters|January 26, 2020
Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Fernanda F Ramos, et al.
Parasitology Research|June 15, 2020
Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cellsPatrícia A F Ribeiro, Daniel S Dias, Daniela P Lage, et al.
Cellular Immunology|November 13, 2017
Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasisDaniel S Dias, Patrícia A F Ribeiro, Vívian T Martins, et al.
Cytokine|February 17, 2020
Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasisPatrícia A F Ribeiro, Danniele L Vale, Daniel S Dias, et al.
Pageof 22